0
Back To Top Jump Location
Sign In  | Cart
Journals | Topic Collections | CME | Guidelines | Subscribe
Left Shadow
Right Shadow
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Clinical Research |  May 21, 2013
Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction: Results of the SELECT-ACS Trial
Jean-Claude Tardif, MD; Jean-François Tanguay, MD; Scott S. Wright, MD; et al.
J Am Coll Cardiol. 2013;61(20):2048-2055. doi:10.1016/j.jacc.2013.03.003.
Clinical Research |  May 07, 2013
Rivaroxaban in Patients Stabilized After a ST-Segment Elevation Myocardial Infarction: Results From the ATLAS ACS-2–TIMI-51 Trial (Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects with Acute Coronary Syndrome–Thrombolysis In Myocardial Infarction-51)
Jessica L. Mega, MD, MPH; Eugene Braunwald, MD; Sabina A. Murphy, MPH; et al.
J Am Coll Cardiol. 2013;61(18):1853-1859. doi:10.1016/j.jacc.2013.01.066.
INCLUDES: Supplemental Content
Practice Guideline |  April 29, 2013 FREE ONLINE FIRST
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Hani Jneid, MD, FACC, FAHA; Jeffrey L. Anderson, MD, FACC, FAHA; R. Scott Wright, MD, FACC, FAHA,; et al.
J Am Coll Cardiol. 2013;():. doi:10.1016/j.jacc.2013.01.014.
Clinical Research |  April 23, 2013
Primary Percutaneous Coronary Intervention: The Deception of Delay⁎⁎ 
Cindy L. Grines, MD; Theodore Schreiber, MD
J Am Coll Cardiol. 2013;61(16):1696-1697. doi:10.1016/j.jacc.2013.01.050.
Clinical Research |  April 23, 2013 FREE
Nonsystem Reasons for Delay in Door-to-Balloon Time and Associated In-Hospital Mortality: A Report From the National Cardiovascular Data Registry
Rajesh V. Swaminathan, MD; Tracy Y. Wang, MD, MHS, MSc; Lisa A. Kaltenbach, MS; et al.
J Am Coll Cardiol. 2013;61(16):1688-1695. doi:10.1016/j.jacc.2012.11.073.
Images in Cardiology |  April 23, 2013
Complete Resolution of ST-Segment Elevation Due to Reversal of Pre-Existing Collateral Flow
Ming-Ming Sim, MD
J Am Coll Cardiol. 2013;61(16):e163-e163. doi:10.1016/j.jacc.2012.08.1041.
Clinical Research |  April 16, 2013
Comparison of Prasugrel and Ticagrelor Loading Doses in ST-Segment Elevation Myocardial Infarction Patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) Primary PCI Study
Guido Parodi, MD, PhD; Renato Valenti, MD; Benedetta Bellandi, MD; et al.
J Am Coll Cardiol. 2013;61(15):1601-1606. doi:10.1016/j.jacc.2013.01.024.
Expedited Publications |  April 02, 2013
Abciximab During Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: Intracoronary, Intravenous, or Not at All?⁎⁎ 
John A. Bittl, MD
J Am Coll Cardiol. 2013;61(13):1455-1457. doi:10.1016/j.jacc.2013.01.042.
Expedited Publications |  April 02, 2013
Intracoronary Compared With Intravenous Bolus Abciximab Application During Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction: Cardiac Magnetic Resonance Substudy of the AIDA STEMI Trial
Ingo Eitel, MD; Jochen Wöhrle, MD; Henning Suenkel, BSc; et al.
J Am Coll Cardiol. 2013;61(13):1447-1454. doi:10.1016/j.jacc.2013.01.048.
Practice Guideline |  January 29, 2013
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Patrick T. O'Gara, MD, FACC, FAHA; Frederick G. Kushner, MD, FACC, FAHA, FSCAI; Deborah D. Ascheim, MD, FACC; et al.
J Am Coll Cardiol. 2013;61(4):e78-e140. doi:10.1016/j.jacc.2012.11.019.
Left Shadow
Right Shadow
logo © 2013 American College of Cardiology Foundation
Powered bySilverchair Information Systems